Etomidate Induction in Hysteroscopic Surgery

Status Not yet recruiting

Clinical Trial Summary

This study intends to study the optimal dose induced by etomidate in outpatients undergoing painless hysteroscopic surgery. At present, the dosage in the user manual is 0.1-0.3mg/kg. In clinical use, it is found that 0.1mg/kg often fails to achieve sedative effect, and 0.3mg/kg is prone to muscle twitching. Therefore, three groups of doses of 0.15mg/kg, 0.2mg/kg and 0.25mg/kg are set. It is hoped that this study will provide a basis for clinical evaluation of etomidate in anesthesia induction of hysteroscopic surgery.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Hysteroscopic Surgery

Clinical Trial Details

NCT number	NCT05520645
Study type	Interventional
Source	Peking University Third Hospital
Contact
Status	Not yet recruiting
Phase	N/A
Start date	August 25, 2022
Completion date	December 30, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01084200` - Comparison of Sevoflurane, Propofol, and Sevoflurane Plus Propofol for Maintenance of Anaesthesia	Phase 4
Completed	`NCT02101827` - Safety and Efficacy of Distending Media Infusion by Manual Syringe Method for Hysteroscopic Procedures	N/A
Completed	`NCT03359655` - A Trial for Peroperative Procedure and Postoperative Pain After Rectal Misoprostol or Rectal Hyoscine Administration	N/A
Completed	`NCT05801172` - Managing Outpatient Hysteroscopy-associated Pain	N/A
Terminated	`NCT04540952` - Comparison of Fluid Capture Efficiency of the Total Capture Drape Versus a Standard Drape for Hysteroscopy	N/A
Recruiting	`NCT00763789` - Local Anaesthesia and Remifentanil Sedation Versus Total Intravenous Anaesthesia for Hysteroscopic Surgery in an Ambulatory Surgery Department.	N/A